Search Results - "Groo, Vicki L."
-
1
Automatic Errors: A Case Series on the Errors Inherent in Electronic Prescribing
Published in Journal of general internal medicine : JGIM (01-07-2016)“…ABSTRACT The adoption of electronic prescribing is on the rise, as it reduces medication errors compared to handwritten orders. The inadvertent dispensing of…”
Get full text
Journal Article -
2
LEVERAGING OUR STRENGTHS: CLINICAL PHARMACIST MEDIATED PCSK9 UTILIZATION
Published in Journal of the American College of Cardiology (21-03-2017)“…Background: Proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors were approved by the FDA in 2015 for patients with atherosclerotic cardiovascular…”
Get full text
Journal Article -
3
HEART FAILURE HOTLINE AS AN INNOVATION TO ADDRESS MEDICATION ISSUES
Published in Journal of the American College of Cardiology (21-03-2017)“…Physicians, nurses, pharmacists, Nurse Practitioners (NP) dieticians, physical therapists, and social workers each have their own office or contact…”
Get full text
Journal Article -
4
Concomitant use of levofloxacin and fluconazole leading to possible torsades de pointes
Published in Journal of oncology pharmacy practice (01-12-2019)“…Prolongation of the corrected QT interval can lead to the deadly arrhythmia torsades de pointes. There are many risk factors for corrected QT prolongation, one…”
Get full text
Journal Article -
5
-
6
Use of a Simplified Nomogram to Individualize Digoxin Dosing versus Standard Dosing Practices in Patients with Heart Failure
Published in Pharmacotherapy (01-11-2014)“…Study Objectives To compare the frequency of achieving a therapeutic serum digoxin concentration (SDC), defined as 0.5–0.9 ng/ml, by using a simplified…”
Get full text
Journal Article -
7
Association of Aldosterone Concentration and Mineralocorticoid Receptor Genotype with Potassium Response to Spironolactone in Patients with Heart Failure
Published in Pharmacotherapy (01-01-2010)“…Study Objective. To identify patient‐specific factors associated with spironolactone‐induced potassium level elevation in patients with heart failure. Design…”
Get full text
Journal Article -
8
Clopidogrel Adherence following Percutaneous Coronary Intervention with a Drug-Eluting Stent in a VA Medical Center
Published in The Journal of pharmacy technology (01-05-2009)“…Background: Antiplatelet therapy with aspirin and a thienopyridine is the standard of care for prevention of thrombosis following coronary stent implantation…”
Get full text
Journal Article -
9
NPPA Genotype Is Associated With Aldosterone Breakthrough in Heart Failure
Published in Journal of cardiac failure (2010)Get full text
Journal Article -
10
TEAM BASED CARE TO IDENTIFY AND TREAT CHEMOTHERAPY INDUCED CARDIOMYOPATHY
Published in Journal of the American College of Cardiology (12-03-2019)Get full text
Journal Article -
11
Effect of Aldosterone Antagonists on Shock Frequency with Implantable Cardioverter Defibrillators
Published in Journal of cardiac failure (01-08-2008)Get full text
Journal Article -
12
Late Onset Hyperkalemia with Spironolactone Therapy
Published in Journal of cardiac failure (01-08-2008)Get full text
Journal Article -
13
Markers of Cardiac Fibrosis Are Similar in African Americans and Caucasians with Heart Failure
Published in Journal of cardiac failure (2007)Get full text
Journal Article -
14
Circulating Aldosterone Is Predictive of Potassium Elevations with Spironolactone in Heart Failure
Published in Journal of cardiac failure (01-08-2008)Get full text
Journal Article -
15
Angiotensinogen Diplotype and Spironolactone Response in Heart Failure
Published in Journal of cardiac failure (2007)Get full text
Journal Article -
16
Association of β-Blocker Dose with Serum Procollagen Concentrations and Cardiac Response to Spironolactone in Patients with Heart Failure
Published in Pharmacotherapy (01-06-2007)“…Study Objective. To determine whether β‐blocker dose influences cardiac collagen turnover and the effects of spironolactone on cardiac collagen turnover in…”
Get full text
Journal Article -
17
Racial differences in potassium response to spironolactone in heart failure
Published in Congestive heart failure (Greenwich, Conn.) (01-07-2006)“…Evidence of racial differences in aldosterone concentrations and K+ disposition suggests that response to aldosterone antagonism might vary by race. The…”
Get more information
Journal Article -
18
Markers of cardiac collagen turnover are similar in patients with mild and more severe symptoms of heart failure
Published in Congestive heart failure (Greenwich, Conn.) (01-09-2007)“…Cardiac fibrosis plays an important role in the pathophysiology of heart failure. The authors sought to determine whether biomarkers of cardiac fibrosis for…”
Get more information
Journal Article -
19
Racial Differences in Patients' Potassium Concentrations During Spironolactone Therapy for Heart Failure
Published in Pharmacotherapy (01-06-2004)“…Study Objective. To determine whether the effects of spironolactone on potassium homeostasis vary by race by comparing serum potassium concentrations and…”
Get full text
Conference Proceeding Journal Article -
20
Abstract 85: Evaluation Of Guideline-Directed Medical Therapy Prescribing In Patients Undergoing Transcatheter Edge-to-Edge Repair
Published in Circulation Cardiovascular quality and outcomes (01-05-2022)“…Abstract only Background: The benefits of guideline-directed medical therapy (GDMT) in heart failure (HF) are well established, but the optimization of GDMT…”
Get full text
Journal Article